"Medicare for All" is getting a lot of press, but its cost may be prohibitive, and it has no chance of surviving health care industry lobbying in Congress. In a co-authored commentary, fellow Vivian Ho suggests instead building on the success of the popular Medicare Advantage program. Read more at The Hill.
